CACNA1D and Parkinson disease: The newer Cav1.3 VGCCs specific dihydropyridine derivate isradipine was shown to be neuroprotective in a mouse model of Parkinson disease [34] and was discussed as a potential strategy for the treatment of Alzheimer disease [35].